PharmaShots | Incisive News in 3 Shots

Subscribe Now

CLN3 Batten Disease

Abeona Signs Exclusive License Agreement with Regenxbio to Develop and Commercialize NAV AAV9 vector

Abeona Signs Exclusive License Agreement with Regenxbio to Develop and Commercialize NAV AAV9 vector

November 6, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us